Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UX003 in pediatric MPS VII (< 5 years)
NCT02418455Phase 2Completed
- Sponsor
- Ultragenyx Pharmaceutical Inc.
- Start
- Jul 2015
- Primary completion
- Mar 2019
- Modality
- Replacement Enzymes
- Countries
- 3
01
Overview
A Phase 2 trial of vestronidase alfa in mucopolysaccharidosis type VII, sponsored by Ultragenyx Pharmaceutical Inc.. Started Jul 2015; status: completed.
02
Drugs
vestronidase alfa
03
Conditions
mucopolysaccharidosis type VII
Beyond the preview
Go deeper on NCT02418455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02418455.